乳腺活检标记物彩色多普勒闪烁伪像在不同代超声平台间的比较
本研究在明胶体模中比较37枚乳腺活检标记物在GE LOGIQ E9与E10两台超声设备上的彩色多普勒闪烁强度。由两名乳腺放射科医师采用0-4分制独立评分。结果显示14枚标记物可测到闪烁,部分在E9上闪烁弱或无临床价值的标记物在E10上达到可操作水平,其中L8-18i探头改善最大。
要点
- 乳腺活检标记物闪烁伪像强度受超声设备代际、探头选择及采集参数明显影响。
- 新一代平台可能使部分既往闪烁不明显的标记物达到可操作的闪烁分值。
- PMMA研究标记物在E9与E10上均表现较高且可重复的闪烁伪像。
核心结论
- 乳腺活检标记物的彩色多普勒闪烁伪像强度受到超声系统代际、探头选择及采集参数的显著影响。
研究设计与样本
- 实验研究,将37枚乳腺活检标记物(36枚市售及1枚PMMA研究标记物)包埋于均匀明胶体模中。
- 使用GE LOGIQ E9与LOGIQ E10两代超声平台,并评价多种线阵与凸阵探头。
- 两名有经验的乳腺放射科医师在两次独立读片中使用0-4有序评分分别评估闪烁强度,≥3分视为具有可操作性的闪烁。
关键影像表现/征象
- 37枚活检标记物中14枚出现可测量的闪烁并进入统计分析。
- 部分在E9上呈现弱或无操作性闪烁的标记物,在E10上获得持续较高且达到可操作水平的评分。
- PMMA标记物在两台系统上均显示持续较高且可重复的闪烁,平均分E9为3.4,E10为3.6。
诊断标准与关键数值
- 闪烁强度评分采用0-4有序量表,分数≥3定义为具有可操作性的闪烁伪像。
- L8-18i探头在E10上较E9的改善最大,比值比OR为251.11(95%CI:67.52-933.88),P<0.001。
临床应用与阅片要点
- 使用彩色多普勒定位乳腺活检标记物时应注意设备代际和探头类型可造成闪烁强度差异。
- 在报告活检标记物定位结果时,需考虑既往显示闪烁弱或无闪烁的标记物在新平台上可能变为可操作。
局限性
- 本研究为体模实验,未在活体乳腺或腋窝组织中验证闪烁伪像表现。
- 仅纳入14枚具有可测量闪烁的标记物进入统计分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Breast biopsy markers are used to mark biopsied tissues in the breast or axilla for potential future surgical excision. This study evaluated the color Doppler twinkling strength of 37 markers using two different ultrasound systems to assess if newer technology provides sufficient twinkling for clinical use.
MATERIALS AND METHODS: Thirty-seven breast biopsy markers (36 commercially available and one polymethyl methacrylate (PMMA) research marker) were embedded in homogeneous gelatin phantoms and imaged using two ultrasound platforms (General Electric LOGIQ E9 and LOGIQ E10). Multiple linear and curvilinear transducers were evaluated. Two experienced breast radiologists independently scored twinkling strength in two separate sessions using an ordinal 0-4 scale, with scores ≥3 considered actionable twinkling. Statistical analyses included intra- and inter-observer reliability assessment, correlation analyses between twinkling scores and imaging parameters, and ordinal logistic regression modeling to evaluate system-, marker-, and transducer-level effects.
RESULTS: Of the 37 biopsy markers evaluated, 14 exhibited measurable twinkling and were included in statistical analyses. Several markers that demonstrated weak or non-actionable twinkling on the E9 achieved consistently higher and actionable scores on the E10. Model-based analysis showed substantial system-dependent differences by transducers, with the L8-18i demonstrating the largest improvement on the E10 (odds ratio (OR) 251.11 [95% CI: 67.52-933.88]; p < 0.001). The PMMA marker demonstrated consistently high and reproducible twinkling across both systems (mean scores: E9 = 3.4, E10 = 3.6).
CONCLUSION: Color Doppler twinkling by breast biopsy markers is strongly influenced by ultrasound system generation, transducer selection, and acquisition parameters.
引用
- Aktharuzzaman, Hesley, Kassmeyer, et al. Does Color Doppler Twinkling Change Between Ultrasound Platform Generations? - A Comparison Using Breast Biopsy Markers. Acad Radiol. 2026. PMID: 42448484. doi:10.1016/j.acra.2026.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。